Explore more publications!
Middle East News Journal
Got News to Share?

Middle East News Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Journal.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on March 4, 2026

Crypto News: Pepeto Surpasses $7.5M And Bitcoin Price Prediction Hits $500,000 and Bull Run Approaches
Mar. 4, 2026

Crypto News: Pepeto Surpasses $7.5M And Bitcoin Price Prediction Hits $500,000 and Bull Run Approaches

Indeterminate GlobeNewswire
HUB Cyber Security Ltd. (Nasdaq: HUBC) Highlights Tivani Expansion Into Defense-Grade Strategic Minerals
Mar. 4, 2026

HUB Cyber Security Ltd. (Nasdaq: HUBC) Highlights Tivani Expansion Into Defense-Grade Strategic Minerals

Indeterminate GlobeNewswire
Silynxcom Wins Government Tender Valued at Approximately $400,000 for Tactical Protective Systems for a Military Force in Asia
Mar. 4, 2026

Silynxcom Wins Government Tender Valued at Approximately $400,000 for Tactical Protective Systems for a Military Force in Asia

Indeterminate GlobeNewswire
Token Security and Its Identity-First AI Agent Security Solution Named Finalist in Two Categories of the 2026 SC Awards
Mar. 4, 2026

Token Security and Its Identity-First AI Agent Security Solution Named Finalist in Two Categories of the 2026 SC Awards

Indeterminate GlobeNewswire
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
Mar. 4, 2026

AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million

Indeterminate GlobeNewswire
ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP
Mar. 4, 2026

ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

Indeterminate GlobeNewswire
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis
Mar. 4, 2026

Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis

Indeterminate GlobeNewswire
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar. 4, 2026

Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Ardelyx to Participate in Upcoming Investor Conferences
Mar. 4, 2026

Ardelyx to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study
Mar. 4, 2026

Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study

Indeterminate GlobeNewswire
Nexxen Reports Fourth Quarter and Full Year 2025 Financial Results
Mar. 4, 2026

Nexxen Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Landmark Data Validate BrainsWay’s SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment
Mar. 4, 2026

Landmark Data Validate BrainsWay’s SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

Indeterminate GlobeNewswire
BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference
Mar. 4, 2026

BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference

Indeterminate GlobeNewswire
NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs
Mar. 4, 2026

NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs

Indeterminate GlobeNewswire
CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies
Mar. 4, 2026

CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies

Indeterminate GlobeNewswire
Tower Semiconductor to Participate at OFC 2026 Highlighting its Silicon Photonics Platform for AI, Telecom and Emerging Applications
Mar. 4, 2026

Tower Semiconductor to Participate at OFC 2026 Highlighting its Silicon Photonics Platform for AI, Telecom and Emerging Applications

Indeterminate GlobeNewswire
Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval
Mar. 4, 2026

Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval

Indeterminate GlobeNewswire
Gilat Secures Multi-Million Dollar IFC Order to Power Commercial Aviation Connectivity
Mar. 4, 2026

Gilat Secures Multi-Million Dollar IFC Order to Power Commercial Aviation Connectivity

Indeterminate GlobeNewswire
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
Mar. 4, 2026

Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute

Indeterminate GlobeNewswire
Boundless Bio to Participate in the Leerink Global Healthcare Conference
Mar. 4, 2026

Boundless Bio to Participate in the Leerink Global Healthcare Conference

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions